BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9548733)

  • 1. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).
    Lijnen HR; Ugwu F; Bini A; Collen D
    Biochemistry; 1998 Apr; 37(14):4699-702. PubMed ID: 9548733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
    Ugwu F; Lemmens G; Collen D; Lijnen HR
    Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9).
    Patterson BC; Sang QA
    J Biol Chem; 1997 Nov; 272(46):28823-5. PubMed ID: 9360944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human glioma cell BT325 expresses a proteinase that converts human plasminogen to kringle 1-5-containing fragments.
    Li F; Yang J; Liu X; He P; Ji S; Wang J; Han J; Chen N; Yao L
    Biochem Biophys Res Commun; 2000 Nov; 278(3):821-5. PubMed ID: 11095991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiostatin-like molecules are generated by snake venom metalloproteinases.
    Ho PL; Serrano SM; Chudzinski-Tavassi AM; Moura da Silva AM; Mentele R; Caldas C; Oliva ML; Batista IF; Oliveira ML
    Biochem Biophys Res Commun; 2002 Jun; 294(4):879-85. PubMed ID: 12061789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
    Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
    Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
    Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
    J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium Sp.
    Lijnen HR; Van Hoef B; Ugwu F; Collen D; Roelants I
    Biochemistry; 2000 Jan; 39(2):479-88. PubMed ID: 10631010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and cellular fibrinolytic activity.
    Lijnen HR
    Biochemistry (Mosc); 2002 Jan; 67(1):92-8. PubMed ID: 11841344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
    Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
    J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP-1 contact sites and perturbations of stromelysin 1 mapped by NMR and a paramagnetic surface probe.
    Arumugam S; Hemme CL; Yoshida N; Suzuki K; Nagase H; Berjanskii M; Wu B; Van Doren SR
    Biochemistry; 1998 Jul; 37(27):9650-7. PubMed ID: 9657677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
    Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
    Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiostatin and plasminogen share binding to endothelial cell surface actin.
    Dudani AK; Ben-Tchavtchavadze M; Porter S; Tackaberry E
    Biochem Cell Biol; 2005 Feb; 83(1):28-35. PubMed ID: 15746964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator.
    Arza B; Hoylaerts MF; Félez J; Collen D; Lijnen HR
    Eur J Biochem; 2000 Nov; 267(21):6378-84. PubMed ID: 11029580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
    Orgel D; Schröder W; Hecker-Kia A; Weithmann KU; Kolkenbrock H; Ulbrich N
    Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiostatin generation by human pancreatic cancer.
    O'Mahony CA; Seidel A; Albo D; Chang H; Tuszynski GP; Berger DH
    J Surg Res; 1998 Jun; 77(1):55-8. PubMed ID: 9698533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
    Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
    BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.